Rooted Wealth Advisors Inc. Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Rooted Wealth Advisors Inc. raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 51.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 864 shares of the healthcare conglomerate’s stock after buying an additional 293 shares during the period. Rooted Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $444,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Genesee Capital Advisors LLC lifted its stake in shares of UnitedHealth Group by 1.9% during the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after purchasing an additional 18 shares during the last quarter. Jmac Enterprises LLC lifted its position in shares of UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after buying an additional 18 shares during the last quarter. Powers Advisory Group LLC grew its position in shares of UnitedHealth Group by 4.8% in the 3rd quarter. Powers Advisory Group LLC now owns 418 shares of the healthcare conglomerate’s stock worth $244,000 after buying an additional 19 shares during the last quarter. Wallace Capital Management Inc. lifted its position in UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock valued at $1,239,000 after acquiring an additional 19 shares during the last quarter. Finally, Western Pacific Wealth Management LP increased its position in shares of UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after purchasing an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Up 0.7 %

UNH opened at $531.31 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a fifty day moving average of $524.58 and a two-hundred day moving average of $563.71. The stock has a market capitalization of $488.96 billion, a price-to-earnings ratio of 34.28, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.